BridgeMD
New treatment option for Gastric Varix
Official title Antibiotic Prophylaxis in Patients Undergoing GVO
ClinicalTrials.gov ID: NCT04140578
What this study is testing
What is Ertapenem?
Ertapenem is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for gastric varix.
Also referred to as Invanz.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 85
You may be able to join if
- Patients with live cirrhosis and/or hepatoma
- Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV
You likely can't join if
- Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD
- Patients recieve antibiotics recently.
- Patients suspected infection.
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.